Skip to content

BD GlaspakRecalls & reported problems across all models

Becton, Dickinson And Company · 2 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

2 open recalls name at least one BD Glaspak model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls
2

We found 2 models of BD Glaspak by Becton, Dickinson And Company in the FDA's device registry (GUDID). Together they are named in 4 adverse event reports in the FDA's MAUDE database, received between Aug 7, 2018 and Jun 24, 2022 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Manufacturing, Packaging or Shipping Problem” (2 reports).

2 FDA recall records name at least one of these models by its device identifier, 2 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

BD Glaspak recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Apr 27, 2026Class IOpen, Classified

    This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.

    Z-2255-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗

  2. Apr 27, 2026Class IOpen, Classified

    This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.

    Z-2250-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗

Most reported BD Glaspak problems

Device problems

  • Manufacturing, Packaging or Shipping Problem2
  • Patient-Device Incompatibility1
  • Volume Accuracy Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Consequences Or Impact To Patient1
  • No Information1

BD Glaspak models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent BD Glaspak adverse event reports

The 4 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Becton, Dickinson And Company products

All Becton, Dickinson And Company devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page